Evidence map›Paper›PMID 27094962›Full record

ArticleAmerican journal of obstetrics and gynecology2016

Host response to synthetic mesh in women with mesh complications.

Alexis L Nolfi, Bryan N Brown, Rui Liang, Stacy L Palcsey, Michael J Bonidie, Steven D Abramowitch, Pamela A Moalli

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04881721 unknown statusnot on this mapstarted 2021, after this paper: background citation

Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial

TypeobservationalSponsorEndeavor HealthRan2021 to 2023Enrolled15ConditionsStress Urinary IncontinenceArmsUrethropexy
NCT05842005 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Mesh-Reduced Sling For Treating Stress Urinary Incontinence, Efficacy and Durability Trial

TypeinterventionalSponsorEndeavor HealthRan2023 to 2024Enrolled15ConditionsStress Urinary IncontinenceArmsMesh-reduced Sling
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Perioperative Opioid Use in Urogynecologic Mesh Removal.Urogynecology (Philadelphia, Pa.) · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alexis L NolfiMagee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA.
Bryan N BrownMagee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA.
Rui LiangMagee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Stacy L PalcseyMagee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA.
Michael J BonidieDepartment of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Steven D AbramowitchDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA.
Pamela A MoalliMagee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA. Electronic address: pmoalli@mail.magee.edu.
University of Pittsburgh · USMagee-Womens Research Institute · USMcGowan Institute for Regenerative Medicine · US

Funding

Building Research Careers in Women's HealthK12HD043441 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI SADOVSKY, YOEL · 2002 to 2023
$10.1M
Porosity and tensioning: Critical factors to consider when choosing a prolapse meshR01HD083383 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI ABRAMOWITCH, STEVEN D, MOALLI, PAMELA A. · 2016 to 2025
$5.5M
Comprehensive Evaluation of Prolapse Meshes by an Interdisciplinary Research TeamR01HD061811 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MOALLI, PAMELA A. · 2009 to 2013
$2.1M
Macrophage Phenotype as a Determinant of Outcome in Pelvic Organ Prolapse RepairR21GM107882 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BROWN, BRYAN NICKLAUS · 2013 to 2014
$387k
NICHD NIH HHS K12 HD043441NICHD NIH HHS R01 HD061811NICHD NIH HHS R01 HD083383NIGMS NIH HHS R21 GM107882
6 · The paper itself

Abstract

backgroundDespite good anatomic and functional outcomes, urogynecologic polypropylene meshes that are used to treat pelvic organ prolapse and stress urinary incontinence are associated with significant complications, most commonly mesh exposure and pain. Few studies have been performed that specifically focus on the host response to urogynecologic meshes. The macrophage has long been known to be the key cell type that mediates the foreign body response. Conceptually, macrophages that respond to a foreign body can be dichotomized broadly into M1 proinflammatory and M2 proremodeling subtypes. A prolonged M1 response is thought to result in chronic inflammation and the formation of foreign body giant cells with potential for ongoing tissue damage and destruction. Although a limited M2 predominant response is favorable for tissue integration and ingrowth, excessive M2 activity can lead to accelerated fibrillar matrix deposition and result in fibrosis and encapsulation of the mesh.

objectiveThe purpose of this study was to define and compare the macrophage response in patients who undergo mesh excision surgery for the indication of pain vs a mesh exposure. STUDY

designPatients who were scheduled to undergo a surgical excision of mesh for pain or exposure at Magee-Womens Hospital were offered enrollment. Twenty-seven mesh-vagina complexes that were removed for the primary complaint of a mesh exposure (n = 15) vs pain in the absence of an exposure (n = 12) were compared with 30 full-thickness vaginal biopsy specimens from women who underwent benign gynecologic surgery without mesh. Macrophage M1 proinflammatory vs M2 proremodeling phenotypes were examined via immunofluorescent labeling for cell surface markers CD86 (M1) vs CD206 (M2) and M1 vs M2 cytokines via enzyme-linked immunosorbent assay. The amount of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) proteolytic enzymes were quantified by zymography and substrate degradation assays, as an indication of tissue matrix degradation. Statistics were performed with the use of 1-way analysis of variance with appropriate post hoc tests, t-tests, and Fisher's Exact test.

resultsTwenty-seven mesh-vaginal tissue complexes were excised from 27 different women with mesh complications: 15 incontinence mid urethral slings and 12 prolapse meshes. On histologic examination, macrophages surrounded each mesh fiber in both groups, with predominance of the M1 subtype. M1 and M2 cytokines/chemokines, MMP-9 (pro- and active), and MMP-2 (active) were increased significantly in mesh-vagina explants, as compared with vagina without mesh. Mesh explants that were removed for exposure had 88.4% higher pro-MMP-9 (P = .035) than those removed for pain. A positive correlation was observed between the profibrotic cytokine interleukin-10 and the percentage of M2 cells (r = 0.697; P = .037) in the pain group.

conclusionIn women with complications, mesh induces a proinflammatory response that persists years after implantation. The increase in MMP-9 in mesh explants that were removed for exposure indicates degradation; the positive association between interleukin-10 and M2 macrophages in mesh explants that are removed for pain is consistent with fibrosis.

Indexed as

AdultFemaleGynecologic Surgical ProceduresHumansMacrophagesMatrix Metalloproteinase 2Matrix Metalloproteinase 9Middle AgedPelvic Organ ProlapseSurgical MeshUrinary Incontinence, StressVaginaMatrix Metalloproteinase 2Matrix Metalloproteinase 9cytokineinflammatory responsemacrophage phenotypepolypropylene mesh

Identifiers

PMID27094962
PMCPMC5201165
OpenAlexW2340208513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.